Figure 3.

Impact of CSU on HRQoL, sleep and daily activities, overall and by angioedema classification. (A) CU‐Q₂oL total and domain scores. Different CU‐Q₂oL scale scores are used in Germany than in Canada, France, Italy, the Netherlands, Spain and the UK. German CU‐Q2oL overall score and scale scores are presented in Figure S2; (B) DLQI total score; (C) DLQI domain scores; (D) Interference with sleep and interference with daily activities over a week, as reported on the Urticaria Patient Daily Diary, by angioedema classification. For all scores, a higher score means higher impairment. *P < .001 (Yes—angioedema vs No—angioedema); **P < .05 (Yes—angioedema vs No—angioedema). Patients who fell into the misaligned category were not included in the statistical comparisons. CU‐Q₂oL, Chronic Urticaria Quality of Life Questionnaire; DLQI, Dermatology Life Quality Index; HRQoL, health‐related quality of life; SD, standard deviation. [Colour figure can be viewed at http://www.wileyonlinelibrary.com/]